AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2005
Feb 23, 2005
34117_dirs_2005-02-23_55478075-f4fc-4009-a92c-31b495923f59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2005-02-18
Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-02-18 | Employee Stock Option | $0.65 | A | 1500000 | Acquired | 2015-02-17 | Common Stock (1500000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6